chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue, Vomiting
Clinical narrative: Diarrhea; Vomiting; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), VOMITING (Vomiting) and FATIGUE (Fatigue) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, the patient experienced DIARRHOEA (Diarrhea), VOMITING (Vomiting) and FATIGUE (Fatigue). At the time of the report, DIARRHOEA (Diarrhea), VOMITING (Vomiting) and FATIGUE (Fatigue) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No relevant concomitant medications were reported. Patient did not use any treatment medications
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema
Clinical narrative: after two weeks her face become red; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (after two weeks her face become red) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced ERYTHEMA (after two weeks her face become red). At the time of the report, ERYTHEMA (after two weeks her face become red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported by reporter. No treatment medications were reported.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Exposure during pregnancy, Headache, Myalgia, Pain
Clinical narrative: welt in left forearm; extreme body aches; maternal exposure during pregnancy; pain in injection site; chills; headache; muscle pain; fever; This spontaneous prospective pregnancy case was reported by a physician and describes the occurrence of URTICARIA (welt in left forearm), PAIN (extreme body aches), EXPOSURE DURING PREGNANCY (maternal exposure during pregnancy), VACCINATION SITE PAIN (pain in injection site) and CHILLS (chills) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included DOXYLAMINE SUCCINATE, PYRIDOXINE HYDROCHLORIDE (DICLEGIS), FOLIC ACID (VITAFOL [FOLIC ACID]), FERROUS SULFATE (SLOW FE), GUAIFENESIN (MUCINEX) and LORATADINE (CLARITIN [LORATADINE]) for an unknown indication.    On 08-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 09-Jul-2020 and the estimated date of delivery was 15-Apr-2021. On 08-Feb-2021, the patient experienced URTICARIA (welt in left forearm), PAIN (extreme body aches), EXPOSURE DURING PREGNANCY (maternal exposure during pregnancy), VACCINATION SITE PAIN (pain in injection site), CHILLS (chills), HEADACHE (headache), MYALGIA (muscle pain) and PYREXIA (fever). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  thirtieth week of the pregnancy.  The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. On 08-Feb-2021, EXPOSURE DURING PREGNANCY (maternal exposure during pregnancy) had resolved. On 09-Feb-2021, URTICARIA (welt in left forearm), PAIN (extreme body aches), CHILLS (chills), HEADACHE (headache), MYALGIA (muscle pain) and PYREXIA (fever) had resolved. At the time of the report, VACCINATION SITE PAIN (pain in injection site) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Urticaria, Vaccination site pain
Clinical narrative: welt in left forearm; extreme body aches; maternal exposure during pregnancy; pain in injection site; chills; headache; muscle pain; fever; This spontaneous prospective pregnancy case was reported by a physician and describes the occurrence of URTICARIA (welt in left forearm), PAIN (extreme body aches), EXPOSURE DURING PREGNANCY (maternal exposure during pregnancy), VACCINATION SITE PAIN (pain in injection site) and CHILLS (chills) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included DOXYLAMINE SUCCINATE, PYRIDOXINE HYDROCHLORIDE (DICLEGIS), FOLIC ACID (VITAFOL [FOLIC ACID]), FERROUS SULFATE (SLOW FE), GUAIFENESIN (MUCINEX) and LORATADINE (CLARITIN [LORATADINE]) for an unknown indication.    On 08-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 09-Jul-2020 and the estimated date of delivery was 15-Apr-2021. On 08-Feb-2021, the patient experienced URTICARIA (welt in left forearm), PAIN (extreme body aches), EXPOSURE DURING PREGNANCY (maternal exposure during pregnancy), VACCINATION SITE PAIN (pain in injection site), CHILLS (chills), HEADACHE (headache), MYALGIA (muscle pain) and PYREXIA (fever). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  thirtieth week of the pregnancy.  The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. On 08-Feb-2021, EXPOSURE DURING PREGNANCY (maternal exposure during pregnancy) had resolved. On 09-Feb-2021, URTICARIA (welt in left forearm), PAIN (extreme body aches), CHILLS (chills), HEADACHE (headache), MYALGIA (muscle pain) and PYREXIA (fever) had resolved. At the time of the report, VACCINATION SITE PAIN (pain in injection site) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure decreased, Chills, Dizziness, Influenza like illness, Myalgia
Clinical narrative: Rash on the injection site about the size of a tennis balls; Itchiness; hotness/sensitive pain-touch; Redness; Head rush; Low blood pressure; Heart palpitations; Chills; Body aches; Night sweats; Extreme are soreness and arm pain; Flu like symptoms; This spontaneous case was reported by a physician and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), CHILLS (Chills), MYALGIA (Body aches), NIGHT SWEATS (Night sweats) and PAIN IN EXTREMITY (Extreme are soreness and arm pain) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 10-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Jan-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms). On 12-Jan-2021, the patient experienced CHILLS (Chills), MYALGIA (Body aches), NIGHT SWEATS (Night sweats) and PAIN IN EXTREMITY (Extreme are soreness and arm pain). On 13-Jan-2021, the patient experienced PALPITATIONS (Heart palpitations). On 15-Jan-2021, the patient experienced DIZZINESS (Head rush) and BLOOD PRESSURE DECREASED (Low blood pressure). On 21-Jan-2021, the patient experienced VACCINATION SITE RASH (Rash on the injection site about the size of a tennis balls), VACCINATION SITE PRURITUS (Itchiness), VACCINATION SITE PAIN (hotness/sensitive pain-touch) and VACCINATION SITE ERYTHEMA (Redness). On 14-Jan-2021, PALPITATIONS (Heart palpitations) had resolved. At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms), CHILLS (Chills), MYALGIA (Body aches), NIGHT SWEATS (Night sweats), PAIN IN EXTREMITY (Extreme are soreness and arm pain), VACCINATION SITE RASH (Rash on the injection site about the size of a tennis balls), VACCINATION SITE PRURITUS (Itchiness), VACCINATION SITE PAIN (hotness/sensitive pain-touch), DIZZINESS (Head rush) and BLOOD PRESSURE DECREASED (Low blood pressure) outcome was unknown and VACCINATION SITE ERYTHEMA (Redness) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medications included Benadryl-one and Motrin- 2. No concomitant medications were provided by reporter.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Night sweats, Pain in extremity, Palpitations, Vaccination site erythema, Vaccination site pain
Clinical narrative: Rash on the injection site about the size of a tennis balls; Itchiness; hotness/sensitive pain-touch; Redness; Head rush; Low blood pressure; Heart palpitations; Chills; Body aches; Night sweats; Extreme are soreness and arm pain; Flu like symptoms; This spontaneous case was reported by a physician and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), CHILLS (Chills), MYALGIA (Body aches), NIGHT SWEATS (Night sweats) and PAIN IN EXTREMITY (Extreme are soreness and arm pain) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 10-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Jan-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms). On 12-Jan-2021, the patient experienced CHILLS (Chills), MYALGIA (Body aches), NIGHT SWEATS (Night sweats) and PAIN IN EXTREMITY (Extreme are soreness and arm pain). On 13-Jan-2021, the patient experienced PALPITATIONS (Heart palpitations). On 15-Jan-2021, the patient experienced DIZZINESS (Head rush) and BLOOD PRESSURE DECREASED (Low blood pressure). On 21-Jan-2021, the patient experienced VACCINATION SITE RASH (Rash on the injection site about the size of a tennis balls), VACCINATION SITE PRURITUS (Itchiness), VACCINATION SITE PAIN (hotness/sensitive pain-touch) and VACCINATION SITE ERYTHEMA (Redness). On 14-Jan-2021, PALPITATIONS (Heart palpitations) had resolved. At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms), CHILLS (Chills), MYALGIA (Body aches), NIGHT SWEATS (Night sweats), PAIN IN EXTREMITY (Extreme are soreness and arm pain), VACCINATION SITE RASH (Rash on the injection site about the size of a tennis balls), VACCINATION SITE PRURITUS (Itchiness), VACCINATION SITE PAIN (hotness/sensitive pain-touch), DIZZINESS (Head rush) and BLOOD PRESSURE DECREASED (Low blood pressure) outcome was unknown and VACCINATION SITE ERYTHEMA (Redness) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medications included Benadryl-one and Motrin- 2. No concomitant medications were provided by reporter.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site rash
Clinical narrative: Rash on the injection site about the size of a tennis balls; Itchiness; hotness/sensitive pain-touch; Redness; Head rush; Low blood pressure; Heart palpitations; Chills; Body aches; Night sweats; Extreme are soreness and arm pain; Flu like symptoms; This spontaneous case was reported by a physician and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), CHILLS (Chills), MYALGIA (Body aches), NIGHT SWEATS (Night sweats) and PAIN IN EXTREMITY (Extreme are soreness and arm pain) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 10-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Jan-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms). On 12-Jan-2021, the patient experienced CHILLS (Chills), MYALGIA (Body aches), NIGHT SWEATS (Night sweats) and PAIN IN EXTREMITY (Extreme are soreness and arm pain). On 13-Jan-2021, the patient experienced PALPITATIONS (Heart palpitations). On 15-Jan-2021, the patient experienced DIZZINESS (Head rush) and BLOOD PRESSURE DECREASED (Low blood pressure). On 21-Jan-2021, the patient experienced VACCINATION SITE RASH (Rash on the injection site about the size of a tennis balls), VACCINATION SITE PRURITUS (Itchiness), VACCINATION SITE PAIN (hotness/sensitive pain-touch) and VACCINATION SITE ERYTHEMA (Redness). On 14-Jan-2021, PALPITATIONS (Heart palpitations) had resolved. At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms), CHILLS (Chills), MYALGIA (Body aches), NIGHT SWEATS (Night sweats), PAIN IN EXTREMITY (Extreme are soreness and arm pain), VACCINATION SITE RASH (Rash on the injection site about the size of a tennis balls), VACCINATION SITE PRURITUS (Itchiness), VACCINATION SITE PAIN (hotness/sensitive pain-touch), DIZZINESS (Head rush) and BLOOD PRESSURE DECREASED (Low blood pressure) outcome was unknown and VACCINATION SITE ERYTHEMA (Redness) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medications included Benadryl-one and Motrin- 2. No concomitant medications were provided by reporter.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy, Pregnancy test
Clinical narrative: got dose of vaccine while  Pregnant; This spontaneous prospective pregnancy case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (got dose of vaccine while  Pregnant) in a 39-year-old female patient (gravida 2, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027L20A and 024M20A) for COVID-19 vaccination.     The patient's past medical history included Vasovagal reaction (cannot remember when the last episode was but it is very infrequent) and Pregnancy (Outcome: Live, full term birth) from July 2018 to 28-Apr-2019. Concurrent medical conditions included Bacterial infection and Drug allergy (to cefaclor, during infancy). Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for an unknown indication.   On 08-Jan-2021 at 11:50 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021 at 12:30 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on 06-Jan-2021 and the estimated date of delivery was 04-Nov-2021. On 08-Jan-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (got dose of vaccine while  Pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) during pregnancy.  On 08-Jan-2021, MATERNAL EXPOSURE DURING PREGNANCY (got dose of vaccine while  Pregnant) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Feb-2021, Pregnancy test: positive (Positive) positive.     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No treatment medication was reported. the date of positive preganancy test was 04 feb 2021.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Fatigue, Gait disturbance, Hordeolum, Malaise
Clinical narrative: Could hardly walk; Sty in eye; Body ached terribly; Body ached terribly, especially her legs,feet; Body ached terribly, especially her legs,feet and back; Tired; Didn't feel good; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Didn't feel good), PAIN (Body ached terribly), PAIN IN EXTREMITY (Body ached terribly, especially her legs,feet), BACK PAIN (Body ached terribly, especially her legs,feet and back) and GAIT DISTURBANCE (Could hardly walk) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included ACHILLEA MILLEFOLIUM, CRATAEGUS MONOGYNA, OLEA EUROPAEA, VALERIANA OFFICINALIS, VISCUM ALBUM (BP (BLOOD PRESSURE)) and THYROID for an unknown indication.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, the patient experienced MALAISE (Didn't feel good). On 05-Feb-2021, the patient experienced FATIGUE (Tired). On 06-Feb-2021, the patient experienced PAIN (Body ached terribly), PAIN IN EXTREMITY (Body ached terribly, especially her legs,feet) and BACK PAIN (Body ached terribly, especially her legs,feet and back). On an unknown date, the patient experienced GAIT DISTURBANCE (Could hardly walk) and HORDEOLUM (Sty in eye). The patient was treated with IBUPROFEN at an unspecified dose and frequency; PARACETAMOL (TYLENOL) at an unspecified dose and frequency and NAPROXEN SODIUM (ALEVE) at an unspecified dose and frequency. At the time of the report, MALAISE (Didn't feel good), PAIN (Body ached terribly), PAIN IN EXTREMITY (Body ached terribly, especially her legs,feet), BACK PAIN (Body ached terribly, especially her legs,feet and back), GAIT DISTURBANCE (Could hardly walk), HORDEOLUM (Sty in eye) and FATIGUE (Tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-086842 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2021: Follow up received on 22/4/2021 :TCR: AE updated, will not complete ADR form.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain in extremity
Clinical narrative: Could hardly walk; Sty in eye; Body ached terribly; Body ached terribly, especially her legs,feet; Body ached terribly, especially her legs,feet and back; Tired; Didn't feel good; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Didn't feel good), PAIN (Body ached terribly), PAIN IN EXTREMITY (Body ached terribly, especially her legs,feet), BACK PAIN (Body ached terribly, especially her legs,feet and back) and GAIT DISTURBANCE (Could hardly walk) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included ACHILLEA MILLEFOLIUM, CRATAEGUS MONOGYNA, OLEA EUROPAEA, VALERIANA OFFICINALIS, VISCUM ALBUM (BP (BLOOD PRESSURE)) and THYROID for an unknown indication.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, the patient experienced MALAISE (Didn't feel good). On 05-Feb-2021, the patient experienced FATIGUE (Tired). On 06-Feb-2021, the patient experienced PAIN (Body ached terribly), PAIN IN EXTREMITY (Body ached terribly, especially her legs,feet) and BACK PAIN (Body ached terribly, especially her legs,feet and back). On an unknown date, the patient experienced GAIT DISTURBANCE (Could hardly walk) and HORDEOLUM (Sty in eye). The patient was treated with IBUPROFEN at an unspecified dose and frequency; PARACETAMOL (TYLENOL) at an unspecified dose and frequency and NAPROXEN SODIUM (ALEVE) at an unspecified dose and frequency. At the time of the report, MALAISE (Didn't feel good), PAIN (Body ached terribly), PAIN IN EXTREMITY (Body ached terribly, especially her legs,feet), BACK PAIN (Body ached terribly, especially her legs,feet and back), GAIT DISTURBANCE (Could hardly walk), HORDEOLUM (Sty in eye) and FATIGUE (Tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-086842 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2021: Follow up received on 22/4/2021 :TCR: AE updated, will not complete ADR form.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Coronavirus test positive, SARS-CoV-2 test positive
Clinical narrative: coronavirus test positive; This spontaneous case was reported by a consumer and describes the occurrence of CORONAVIRUS TEST POSITIVE (coronavirus test positive) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Jan-2021, the patient experienced CORONAVIRUS TEST POSITIVE (coronavirus test positive). At the time of the report, CORONAVIRUS TEST POSITIVE (coronavirus test positive) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Jan-2021, SARS-CoV-2 test positive: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.   Patient was given monoclonal antibody infusion for treatment
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Pain in extremity, Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: arm around the injection site was swollen, red, warm, and itchy; arm around the injection site was swollen, red, warm, and itchy; arm around the injection site was swollen, red, warm, and itchy; arm around the injection site was swollen, red, warm, and itchy; little lightheadedness; little bit of pain in her arm; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (little lightheadedness), PAIN IN EXTREMITY (little bit of pain in her arm), VACCINATION SITE WARMTH (arm around the injection site was swollen, red, warm, and itchy), VACCINATION SITE PRURITUS (arm around the injection site was swollen, red, warm, and itchy) and VACCINATION SITE ERYTHEMA (arm around the injection site was swollen, red, warm, and itchy) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced PAIN IN EXTREMITY (little bit of pain in her arm). On 09-Feb-2021, the patient experienced DIZZINESS (little lightheadedness), VACCINATION SITE WARMTH (arm around the injection site was swollen, red, warm, and itchy), VACCINATION SITE PRURITUS (arm around the injection site was swollen, red, warm, and itchy), VACCINATION SITE ERYTHEMA (arm around the injection site was swollen, red, warm, and itchy) and VACCINATION SITE SWELLING (arm around the injection site was swollen, red, warm, and itchy). At the time of the report, DIZZINESS (little lightheadedness), PAIN IN EXTREMITY (little bit of pain in her arm), VACCINATION SITE WARMTH (arm around the injection site was swollen, red, warm, and itchy), VACCINATION SITE PRURITUS (arm around the injection site was swollen, red, warm, and itchy), VACCINATION SITE ERYTHEMA (arm around the injection site was swollen, red, warm, and itchy) and VACCINATION SITE SWELLING (arm around the injection site was swollen, red, warm, and itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.    No treatment information was provided
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: arm around the injection site was swollen, red, warm, and itchy; arm around the injection site was swollen, red, warm, and itchy; arm around the injection site was swollen, red, warm, and itchy; arm around the injection site was swollen, red, warm, and itchy; little lightheadedness; little bit of pain in her arm; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (little lightheadedness), PAIN IN EXTREMITY (little bit of pain in her arm), VACCINATION SITE WARMTH (arm around the injection site was swollen, red, warm, and itchy), VACCINATION SITE PRURITUS (arm around the injection site was swollen, red, warm, and itchy) and VACCINATION SITE ERYTHEMA (arm around the injection site was swollen, red, warm, and itchy) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced PAIN IN EXTREMITY (little bit of pain in her arm). On 09-Feb-2021, the patient experienced DIZZINESS (little lightheadedness), VACCINATION SITE WARMTH (arm around the injection site was swollen, red, warm, and itchy), VACCINATION SITE PRURITUS (arm around the injection site was swollen, red, warm, and itchy), VACCINATION SITE ERYTHEMA (arm around the injection site was swollen, red, warm, and itchy) and VACCINATION SITE SWELLING (arm around the injection site was swollen, red, warm, and itchy). At the time of the report, DIZZINESS (little lightheadedness), PAIN IN EXTREMITY (little bit of pain in her arm), VACCINATION SITE WARMTH (arm around the injection site was swollen, red, warm, and itchy), VACCINATION SITE PRURITUS (arm around the injection site was swollen, red, warm, and itchy), VACCINATION SITE ERYTHEMA (arm around the injection site was swollen, red, warm, and itchy) and VACCINATION SITE SWELLING (arm around the injection site was swollen, red, warm, and itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.    No treatment information was provided
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy
Clinical narrative: Pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Pregnant) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Pregnant.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On an unknown date, the patient experienced EXPOSURE DURING PREGNANCY (Pregnant). At the time of the report, EXPOSURE DURING PREGNANCY (Pregnant) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medicines  were reported.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site reaction
Clinical narrative: Starting to have a reaction-injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (Starting to have a reaction-injection site) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (Starting to have a reaction-injection site). At the time of the report, VACCINATION SITE REACTION (Starting to have a reaction-injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication reported   No treatment medication reported
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Vaccination site induration, Vaccination site pain, Vaccination site swelling
Clinical narrative: patient's arm is still hard; swollen; sore; constant headache; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INDURATION (patient's arm is still hard), VACCINATION SITE SWELLING (swollen), VACCINATION SITE PAIN (sore) and HEADACHE (constant headache) in an 87-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     Concomitant products included PARACETAMOL (TYLENOL) for Headache.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE INDURATION (patient's arm is still hard), VACCINATION SITE SWELLING (swollen), VACCINATION SITE PAIN (sore) and HEADACHE (constant headache). At the time of the report, VACCINATION SITE INDURATION (patient's arm is still hard), VACCINATION SITE SWELLING (swollen), VACCINATION SITE PAIN (sore) and HEADACHE (constant headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. Patients wife reported, her husband takes acetaminophen (paracetamol) for constant headache, he always takes it a lot.    Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 14-Apr-2021: reporter declined Follow-up said "her husband is fine now; it was a while ago and I don't share email address.
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy
Clinical narrative: pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (pregnant) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On an unknown date, the patient experienced EXPOSURE DURING PREGNANCY (pregnant). At the time of the report, EXPOSURE DURING PREGNANCY (pregnant) had resolved.            No relevant concomitant medications were reported. No adverse events were reported so treatment is not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 12-Feb-2021: unable to get in touch with patient, left voice mail, no new information available
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Insomnia, Malaise, Nausea
Clinical narrative: feeling sick; diarrhea; not able to sleep all night; rash; redness; Chills; feeling nauseated; Vomiting all night; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (feeling sick), DIARRHOEA (diarrhea), INSOMNIA (not able to sleep all night), INJECTION SITE RASH (rash) and INJECTION SITE ERYTHEMA (redness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included INSULIN for an unknown indication.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Jan-2021, the patient experienced MALAISE (feeling sick), DIARRHOEA (diarrhea), INSOMNIA (not able to sleep all night), INJECTION SITE RASH (rash), INJECTION SITE ERYTHEMA (redness), CHILLS (Chills), NAUSEA (feeling nauseated) and VOMITING (Vomiting all night). The patient was treated with ELECTROLYTES NOS, GLUCOSE (PEDIALYTE [ELECTROLYTES NOS;GLUCOSE]) (oral) on 22-Jan-2021 for Vomiting, at an unspecified dose and frequency. At the time of the report, MALAISE (feeling sick), DIARRHOEA (diarrhea), INSOMNIA (not able to sleep all night), INJECTION SITE RASH (rash), INJECTION SITE ERYTHEMA (redness), CHILLS (Chills), NAUSEA (feeling nauseated) and VOMITING (Vomiting all night) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       In addition to four insulin shots patient reported using a lot of other medications concomitantly (not specif   Most recent FOLLOW-UP information incorporated above includes: On 14-Apr-2021: Event outcome updated. patient said she followed up with her HCP, she has underlying conditions which caused adverse events she is fine now and declined further follow ups.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site rash, Vomiting
Clinical narrative: feeling sick; diarrhea; not able to sleep all night; rash; redness; Chills; feeling nauseated; Vomiting all night; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (feeling sick), DIARRHOEA (diarrhea), INSOMNIA (not able to sleep all night), INJECTION SITE RASH (rash) and INJECTION SITE ERYTHEMA (redness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included INSULIN for an unknown indication.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Jan-2021, the patient experienced MALAISE (feeling sick), DIARRHOEA (diarrhea), INSOMNIA (not able to sleep all night), INJECTION SITE RASH (rash), INJECTION SITE ERYTHEMA (redness), CHILLS (Chills), NAUSEA (feeling nauseated) and VOMITING (Vomiting all night). The patient was treated with ELECTROLYTES NOS, GLUCOSE (PEDIALYTE [ELECTROLYTES NOS;GLUCOSE]) (oral) on 22-Jan-2021 for Vomiting, at an unspecified dose and frequency. At the time of the report, MALAISE (feeling sick), DIARRHOEA (diarrhea), INSOMNIA (not able to sleep all night), INJECTION SITE RASH (rash), INJECTION SITE ERYTHEMA (redness), CHILLS (Chills), NAUSEA (feeling nauseated) and VOMITING (Vomiting all night) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       In addition to four insulin shots patient reported using a lot of other medications concomitantly (not specif   Most recent FOLLOW-UP information incorporated above includes: On 14-Apr-2021: Event outcome updated. patient said she followed up with her HCP, she has underlying conditions which caused adverse events she is fine now and declined further follow ups.
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia, Pain in extremity
Clinical narrative: Metallic taste in her mouth; right arm hurting a little; This spontaneous case was reported by a patient (subsequently medically confirmed) and describes the occurrence of DYSGEUSIA (Metallic taste in her mouth) and PAIN IN EXTREMITY (right arm hurting a little) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 340P) for COVID-19 vaccination.     Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced PAIN IN EXTREMITY (right arm hurting a little). On 13-Feb-2021, the patient experienced DYSGEUSIA (Metallic taste in her mouth). At the time of the report, DYSGEUSIA (Metallic taste in her mouth) outcome was unknown and PAIN IN EXTREMITY (right arm hurting a little) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications were used.   Reporter did not allow further contact
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Pregnancy
Clinical narrative: Pregnant; This spontaneous prospective pregnancy case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PREGNANCY (pregnant) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.  No Medical History information was reported.   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 07-May-2020 and the estimated date of delivery was 07-Feb-2021. On 12-Jan-2021, the patient experienced PREGNANCY (pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the thirty-fifth week of the pregnancy. On 12-Jan-2021, PREGNANCY (pregnant) had resolved.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.  No relevant concomitant medications were provided by the reporter. It was reported that at that the time of this report the patient was 36 weeks and 2 days pregnant. Treatment information is not applicable.  Most recent FOLLOW-UP information incorporated above includes: On 10-Feb-2021: Internal review conducted on 20-JUL-2021, resulted in updates to the pregnancy details.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Cough, Headache, Hypersomnia, Nasopharyngitis
Clinical narrative: dry cough; slept quite a bit; had a slight cold; low-grade fever; nagging headache; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of COUGH (dry cough), HYPERSOMNIA (slept quite a bit), NASOPHARYNGITIS (had a slight cold), PYREXIA (low-grade fever) and HEADACHE (nagging headache) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy and Drug allergy (to sulfa drugs). Concomitant products included MULTIVITAMIN [VITAMINS NOS], CURCUMIN (TURMERIC MERIVA) and CALCIUM CITRATE (CALCITRATE) for an unknown indication.    On 19-Jan-2021 at 9:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jan-2021, the patient experienced COUGH (dry cough) and PYREXIA (low-grade fever). 24-Jan-2021, the patient experienced HYPERSOMNIA (slept quite a bit), NASOPHARYNGITIS (had a slight cold) and HEADACHE (nagging headache). On 28-Jan-2021, COUGH (dry cough), HYPERSOMNIA (slept quite a bit), NASOPHARYNGITIS (had a slight cold), PYREXIA (low-grade fever) and HEADACHE (nagging headache) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Jan-2021, SARS-CoV-2 test: negative (Negative) negative. On 22-Jan-2021, Body temperature: 100.4 degree F.     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing was delayed on an unknown date.       Patient reports "We have a former exchange student, who comes to stay with us periodically for work. He came in on January 11th. We waited 5 days and then my husband and I were tested on January 15th and our visitor was tested on January 16th. We did this as a precautionary measure. They both tested positive but were asymptomatic. I tested negative." On 02Feb2021 patient received a monoclonal antibody infusion. She has not yet received the second planned vaccine dose because she was told to wait 90 days after the infusion.   Most recent FOLLOW-UP information incorporated above includes: On 15-Apr-2021: Follow-up information received 15-Apr-2021 processed with initial report. Updates included added event details and lab test., added patient allergy and treatment recived.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test
Clinical narrative: dry cough; slept quite a bit; had a slight cold; low-grade fever; nagging headache; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of COUGH (dry cough), HYPERSOMNIA (slept quite a bit), NASOPHARYNGITIS (had a slight cold), PYREXIA (low-grade fever) and HEADACHE (nagging headache) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy and Drug allergy (to sulfa drugs). Concomitant products included MULTIVITAMIN [VITAMINS NOS], CURCUMIN (TURMERIC MERIVA) and CALCIUM CITRATE (CALCITRATE) for an unknown indication.    On 19-Jan-2021 at 9:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jan-2021, the patient experienced COUGH (dry cough) and PYREXIA (low-grade fever). 24-Jan-2021, the patient experienced HYPERSOMNIA (slept quite a bit), NASOPHARYNGITIS (had a slight cold) and HEADACHE (nagging headache). On 28-Jan-2021, COUGH (dry cough), HYPERSOMNIA (slept quite a bit), NASOPHARYNGITIS (had a slight cold), PYREXIA (low-grade fever) and HEADACHE (nagging headache) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Jan-2021, SARS-CoV-2 test: negative (Negative) negative. On 22-Jan-2021, Body temperature: 100.4 degree F.     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing was delayed on an unknown date.       Patient reports "We have a former exchange student, who comes to stay with us periodically for work. He came in on January 11th. We waited 5 days and then my husband and I were tested on January 15th and our visitor was tested on January 16th. We did this as a precautionary measure. They both tested positive but were asymptomatic. I tested negative." On 02Feb2021 patient received a monoclonal antibody infusion. She has not yet received the second planned vaccine dose because she was told to wait 90 days after the infusion.   Most recent FOLLOW-UP information incorporated above includes: On 15-Apr-2021: Follow-up information received 15-Apr-2021 processed with initial report. Updates included added event details and lab test., added patient allergy and treatment recived.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Fall, Gait inability, Vaccination site pain
Clinical narrative: Unable to walk,could not get himself up off of the toilet.; fell to the floor, and was on the floor for 2 hours; he was just too weak; Sore arm in the evening; This spontaneous case was reported by a consumer and describes the occurrence of GAIT INABILITY (Unable to walk,could not get himself up off of the toilet.), FALL (fell to the floor, and was on the floor for 2 hours), ASTHENIA (he was just too weak) and VACCINATION SITE PAIN (Sore arm in the evening) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 on 25-Oct-2020 and Clot blood on 14-Nov-2020. Concomitant products included METFORMIN, APIXABAN (ELIQUIS), POTASSIUM, ATORVASTATIN, LISINOPRIL and VITAMIN C [ASCORBIC ACID] for an unknown indication.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Jan-2021, the patient experienced VACCINATION SITE PAIN (Sore arm in the evening). On 31-Jan-2021, the patient experienced GAIT INABILITY (Unable to walk,could not get himself up off of the toilet.), FALL (fell to the floor, and was on the floor for 2 hours) and ASTHENIA (he was just too weak). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, GAIT INABILITY (Unable to walk,could not get himself up off of the toilet.), FALL (fell to the floor, and was on the floor for 2 hours), ASTHENIA (he was just too weak) and VACCINATION SITE PAIN (Sore arm in the evening) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to MOD-2021-159203 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 10-Feb-2021: Follow up received on 26-5-21.  Adverse Event form added with details of second dose
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy, Pregnancy test
Clinical narrative: Pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Pregnant) in a 38-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     Concurrent medical conditions included Hashimoto's disease since 2001. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for Hashimoto's disease, MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for for pregnancy.    On 08-Feb-2021 at 9:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 24-Sep-2020 and the estimated date of delivery was 18-Jul-2021. On 08-Feb-2021, the patient experienced EXPOSURE DURING PREGNANCY (Pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  nineteenth week of the pregnancy. The delivery occurred on an unknown date.  On 08-Feb-2021, EXPOSURE DURING PREGNANCY (Pregnant) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Nov-2020, Pregnancy test: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient reported her pregnancy is through In Vitro Fertilization since her husband is quadraplegic